The antibody cocktail is excellent for discrimination of simple epithelia from those of different origin. Tumors specifically detected: all adenocarcinoma; mammary carcinoma, urinary bladder carcinoma, undifferentiated carcinoma, cervix carcinoma, hepatocellular carcinoma. Polypeptide reacting: Mr 45 kD (keratin K18) of all simple type epithelia and basal cells of many squamous, nonepidermal epithelia.    	
    
        
        
        		
						
							
				
							
				
					| Host | 
					mouse | 
				
					
				
					| Antibody Type | 
					monoclonal | 
				
					
				
					| Isotype | 
					IgG1 | 
				
					
				
					| Clone | 
					Ks18.04 + 18.27 + 18.5 + 9B1 + 18.174 | 
				
					
				
					| Immunogen | 
					Keratin K18 of human and bovine origin | 
				
					
				
					| Purification | 
					hybridoma cell culture supernatant | 
				
					
				
					| Conjugate | 
					unconjugated | 
				
					
				
					| Formulation | 
					contains 0.09% sodium azide | 
				
					
				
					| Storage | 
					short term at 2  – 8 °C; long term storage in aliquots at  - 20 °C; avoid freeze/ thaw  cycles  | 
				
				
					| Tested species reactivity | 
					human, mammals (most mammals incl. mouse, rat, sheep, bovine, pig, dog, hamster) | 
				
        
    
    	
    
        
        
        
                  
		  | Tested applications | 
		  Tested dilutions
         | 
		
				
									
				
							
				
					| Immunocytochemistry (ICC)/ Immunofluorescence (IF) | 
					assay dependent | 
				
					
				
					| Immunohistochemistry (IHC) - frozen | 
					ready-to-use | 
				
					
				
					| Immunohistochemistry (IHC) - paraffin | 
					ready-to-use (microwave treatment recommended) | 
				
					
				
					| Western Blot (WB) | 
					assay dependent | 
				
        
    
                             
                            
                                  自1983年以来,PROGEN一直为全球生命科学研究提供高品质的抗体、体外诊断产品和试剂。公司多元化的产品吸引和服务了大学、研究机构、制药公司、生物技术公司以及私人和临床实验室。 PROGEN的抗体是各种生物医学和细胞生物学文献中最广泛使用的抗体之一,同时其ELISA试剂盒也瞄准了微生物学、传染病和免疫学领域的细分市场。凭借强有力的核心竞争力和免疫化学中的丰富经验,公司近年来扩大其产品和服务组合,包括重组抗体工程、抗体噬菌体展示技术、密度梯度介质和进行基因治疗研究使用的AAV检测试剂盒。
       自2012年起,PROGEN成为位于德国达姆施塔特的拜发公司(R-Biopharm AG)的全资子公司。此外,PROGEN将同拜发集团和合作伙伴一起扩大现有市场,进入新的市场。